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1746 Staged repair of pulmonary atresia with ventricular septal defect and major
aortopulmonary collateral arteries: Experience with 104 patients
Anuja Gupta, MD, Jonah Odim, MD, Daniel Levi, MD, Ruey-Kang Chang, MD, MPH,
and Hillel Laks, MD, Los Angeles, Calif
One hundred four patients with pulmonary atresia with VSD and MAPCAs were treated using
the staged repair; 56% of patients achieved complete repair. The 10-year mortality was 16.5%.
After completion of repair, the pressure ratio between the right and left ventricles was 0.5.
1753 Prevalence and predictors of neoaortic regurgitation after arterial switch
operation for transposition of the great arteries
Roberto Formigari, MD, FACC, Alessandra Toscano, MD, Alessandro Giardini, MD,
Gaetano Gargiulo, MD, Roberto Di Donato, MD, Fernando M. Picchio, MD, FESC,
and Luciano Pasquini, MD, Bologna and Rome, Italy
Children who have received arterial switch operations may develop progressive regurgitation of
the neoaortic valve. In this cohort of 173 patients, neoaortic regurgitation was observed in 35%;
the technique of coronary reimplantation was the only independent risk factor for late
dysfunction of the systemic semilunar valve.
1760 Impaired systemic ventricular relaxation affects postoperative short-term
outcome in Fontan patients
William L. Border, MBChB, Aitizaz U. Syed, FRCS Ed, Erik C. Michelfelder, MD,
Philip Khoury, MS, Karen C. Uzark, PhD, Peter B. Manning, MD, and
Jeffrey M. Pearl, MD, Cincinnati, Ohio
Preoperative systemic ventricular tau values significantly predicted length of ICU stay and
hospital stay in patients undergoing the Fontan operation. This demonstrates the important role
of systemic ventricular relaxation and early diastolic filling in these patients and suggests that a
more comprehensive diastolic assessment is warranted in the preoperative period.
1765 The influence of hemodilution on outcome after hypothermic
cardiopulmonary bypass: Results of a randomized trial in infants
Richard A. Jonas, MD, David Wypij, PhD, Stephen J. Roth, MD, MPH, David C. Bellinger,
PhD, MSc, Karen J. Visconti, PhD, Adre J. du Plessis, MBChB, MPH, Howard Goodkin, MD,
Peter C. Laussen, MD, David M. Farrell, MACCP, Jodi Bartlett, RN, Ellen McGrath, RN,
Leonard J. Rappaport, MD, Emile A. Bacha, MD, Joseph M. Forbess, MD, Pedro J. del Nido,
MD, John E. Mayer, Jr, MD, and Jane W. Newburger, MD, MPH, Boston, Mass
In a single-center randomized trial with blinded assessment of outcomes, we compared use of 2
hemodilution protocols during hypothermic cardiopulmonary bypass (CPB) for infant cardiac
surgery. Hemodilution to a hematocrit level in wide use for CPB and previously thought to be
safe is associated with adverse perioperative and developmental outcomes in infants.
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